Literature DB >> 9327458

Iontophoretic delivery across the skin: electroosmosis and its modulation by drug substances.

J Hirvonen1, R H Guy.   

Abstract

PURPOSE: The long-term objective of this research is to understand how the efficiency of iontophoresis depends upon the structural and physicochemical properties of the administered drug. Specifically, the ability of certain drug species to alter the permselective properties of the skin was examined.
METHODS: Using conventional in vitro methodology, the inhibition of electroosmotic flow induced by the iontophoresis of five different beta-blockers (of varying lipophilicity) was examined. The concomitant electrotransport of the most lipophilic species (propranolol) and the convective movement of solvent in the anode-to-cathode direction were measured. In addition, the possibility that electroosmosis might be augmented by the delivery of anionic drugs was also considered.
RESULTS: Iontophoresis of lipophilic, cationic beta-blockers caused a concentration-dependent inhibition of conventional electroosmosis. The most hydrophilic analogs elicited no effect. As a result of this charge neutralization phenomenon, the optimal concentration for propranolol iontophoresis was significantly less than the maximum achievable in aqueous solution. Only a very modest improvement in convective solvent flow was induced by the cathodal iontophoresis of anionic compounds.
CONCLUSIONS: The permselectivity of the skin can be altered by drugs which are positively charged and which possess a significant, adjacent hydrophobic surface. The latter seems able to "anchor" the molecule in the skin and the counter charge to the membrane's negative character ensures a tight association. Both lipophilicity and a positive charge are essential-without either, the phenomenon is not observed. The conformational flexibility of the drugs studied to-date, however, prevents unambiguous conclusions about the three-dimensional nature of the putative "binding site".

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9327458     DOI: 10.1023/a:1012127512251

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  Iontophoretic delivery of amino acids and amino acid derivatives across the skin in vitro.

Authors:  P G Green; R S Hinz; C Cullander; G Yamane; R H Guy
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

2.  Transdermal delivery of peptides by iontophoresis.

Authors:  J Hirvonen; Y N Kalia; R H Guy
Journal:  Nat Biotechnol       Date:  1996-12       Impact factor: 54.908

3.  A new system for in vitro studies of iontophoresis.

Authors:  P Glikfeld; C Cullander; R S Hinz; R H Guy
Journal:  Pharm Res       Date:  1988-07       Impact factor: 4.200

4.  Corneal penetration behavior of beta-blocking agents I: Physiochemical factors.

Authors:  R D Schoenwald; H S Huang
Journal:  J Pharm Sci       Date:  1983-11       Impact factor: 3.534

5.  Characterization of the permselective properties of excised human skin during iontophoresis.

Authors:  R R Burnette; B Ongpipattanakul
Journal:  J Pharm Sci       Date:  1987-10       Impact factor: 3.534

6.  Flow-through system effects on in vitro analysis of transdermal systems.

Authors:  J Sclafani; J Nightingale; P Liu; T Kurihara-Bergstrom
Journal:  Pharm Res       Date:  1993-10       Impact factor: 4.200

7.  Characterization of convective solvent flow during iontophoresis.

Authors:  M B Delgado-Charro; R H Guy
Journal:  Pharm Res       Date:  1994-07       Impact factor: 4.200

8.  Reverse iontophoresis: development of a noninvasive approach for glucose monitoring.

Authors:  G Rao; P Glikfeld; R H Guy
Journal:  Pharm Res       Date:  1993-12       Impact factor: 4.200

9.  Effect of current magnitude and drug concentration on iontophoretic delivery of octreotide acetate (Sandostatin) in the rabbit.

Authors:  D T Lau; J W Sharkey; L Petryk; F A Mancuso; Z Yu; F L Tse
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

10.  Measurement of glucose in diabetic subjects using noninvasive transdermal extraction.

Authors:  J A Tamada; N J Bohannon; R O Potts
Journal:  Nat Med       Date:  1995-11       Impact factor: 53.440

  10 in total
  12 in total

1.  Transdermal delivery of timolol and atenolol using electroporation and iontophoresis in combination: a mechanistic approach.

Authors:  Anne-Rose Denet; Bernard Ucakar; Véronique Préat
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

2.  Transdermal iontophoretic delivery of vapreotide acetate across porcine skin in vitro.

Authors:  Yannic B Schuetz; Aarti Naik; Richard H Guy; Evelyne Vuaridel; Yogeshvar N Kalia
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

3.  Epidermal iontophoresis: II. Application of the ionic mobility-pore model to the transport of local anesthetics.

Authors:  P M Lai; M S Roberts
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

4.  Permeability profiles of M-alkoxysubstituted pyrrolidinoethylesters of phenylcarbamic acid across caco-2 monolayers and human skin.

Authors:  Lenka Gyürösiová; Leena Laitinen; Johanna Raiman; Jozef Cizmárik; Eva Sedlárová; Jouni Hirvonen
Journal:  Pharm Res       Date:  2002-02       Impact factor: 4.200

5.  Iontophoretic delivery of ropinirole hydrochloride: effect of current density and vehicle formulation.

Authors:  A Luzardo-Alvarez; M B Delgado-Charro; J Blanco-Méndez
Journal:  Pharm Res       Date:  2001-12       Impact factor: 4.200

6.  Contributions of electromigration and electroosmosis to iontophoretic drug delivery.

Authors:  D Marro; Y N Kalia; M B Delgado-Charro; R H Guy
Journal:  Pharm Res       Date:  2001-12       Impact factor: 4.200

7.  Epidermal iontophoresis: I. Development of the ionic mobility-pore model.

Authors:  M S Roberts; P M Lai; Y G Anissimov
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

8.  Iontophoretic in vivo transdermal delivery of beta-blockers in hairless rats and reduced skin irritation by liposomal formulation.

Authors:  Rajkumar Conjeevaram; Ayyappa Chaturvedula; Guru V Betageri; Gangadhar Sunkara; Ajay K Banga
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

9.  Transdermal delivery of cytochrome C--A 12.4 kDa protein--across intact skin by constant-current iontophoresis.

Authors:  J Cázares-Delgadillo; A Naik; A Ganem-Rondero; D Quintanar-Guerrero; Y N Kalia
Journal:  Pharm Res       Date:  2007-04-25       Impact factor: 4.200

10.  Transdermal iontophoresis of rotigotine across human stratum corneum in vitro: influence of pH and NaCl concentration.

Authors:  Akhmad Kharis Nugroho; Gai Ling Li; Meindert Danhof; Joke A Bouwstra
Journal:  Pharm Res       Date:  2004-05       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.